Understanding treatment resistance in prostate cancer @uclcancer. Tweets by Gert & team.
Sep 19, 2021 • 6 tweets • 5 min read
Excited to share the latests results from the STAMPEDE clinical trial: abiraterone plus prednisolone with or without enza added to ADT compared to ADT alone in high risk nonmetastatic #prostatecancer patients #ESMO21
None of this would be possible without all the patients, supported by their family/friends, all the site staff involved in the trial, our pharma partners @AstellasEurope@JanssenUK, our funders @The_MRC@CR_UK, and the efforts of the whole team @MRCCTU#ESMO21